Analgesics in Taiwan
ANALGESICS IN TAIWAN
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Sales Growth in Analgesics Slowing Down As These Products Are Seen As Unhealthy
Topical Analgesics Set To Remain the Dominant Analgesics Category
Acetaminophen Remains the Most Popular Category of Systemic Analgesics
Competitive Landscape
Leading Player GlaxoSmithKline Remains Well Out in Front
Topical Analgesics/anaesthetic Brands Round Out the Top Five Names in Analgesics
Advertising Campaigns Featuring Doctors Remain A Popular Form of Marketing
Category Data
Table 1 Sales of Analgesics by Category: Value 2013-2018
Table 2 Sales of Analgesics by Category: % Value Growth 2013-2018
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018
Table 4 NBO Company Shares of Analgesics: % Value 2014-2018
Table 5 LBN Brand Shares of Analgesics: % Value 2015-2018
Table 6 Forecast Sales of Analgesics by Category: Value 2018-2023
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023
Executive Summary
Pending OTC Switches Remain in the Pipeline Due To Medical Community Opposition
Sales Growth Boosted by Increasingly Busy Lifestyles Among Urban Consumers
Leading Brands Face Competition From Private Labels of Drugstores/parapharmacies
Health and Beauty Specialist Retailers Dominant in the Distribution of Consumer Health
Rising Interest in Self-medication To Support Sales Growth in Consumer Health
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018
Market Data
Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format and Category: % Value 2018
Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 1 Research Sources
Although Taiwanese people have traditionally consumed high volumes of analgesics, rising health awareness has led to rising concerns about the potential side-effects of painkillers on the stomach and kidneys. This continued to suppress sales growth in analgesics in 2018 and aspirin in particular is likely to continue recording falling demand over the forecast period. Although the long-term safety of aspirin and other types of systemic analgesics is still under question, falling demand is not exp...
Euromonitor International's Analgesics in Taiwan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.